Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The myrosinase-glucosinolate system, its organisation and biochemistry
This serves as a proxy to assess whether the binder could attain the designed structure by itself, which we use to filter out designs that are likely to require a significant conformational change upon binding or do not express since they do not fold into a stable structure by themselves
Cardiovascular risk2.4mg/wk The dose tested in the cardiovascular outcomes trial, which cut major adverse cardiovascular events by 20% in people with established cardiovascular disease and no diabetes
If any adverse reactions occur, discontinue use and consult a healthcare professional
US$ 24.86
US$ 29.88
US$ 28.05
US$ 29.86
US$ 22.54
